![]()
|
|
||||||||
J. Biol. Chem., Vol. 278, Issue 15, 13244-13256, April 11, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Departments of The ATP-binding cassette transporter
A1 (ABCA1) is a major regulator of peripheral cholesterol efflux and
plasma high density lipoprotein metabolism. In adult rat brain
we found high expression of ABCA1 in neurons in the hypothalamus,
thalamus, amygdala, cholinergic basal forebrain, and hippocampus. Large
neurons of the cholinergic nucleus basalis together with CA1 and CA3
pyramidal neurons were among the most abundantly immunolabeled neurons.
Glia cells were largely negative. Because cholesterol homeostasis may
have an essential role in central nervous system function and
neurodegeneration, we examined ABCA1 expression and function in
different brain cell types using cultures of primary neurons,
astrocytes, and microglia isolated from embryonic rat brain. The basal
ABCA1 mRNA and protein levels detected in these cell types were
increased markedly after exposure to oxysterols and
9-cis-retinoic acid, which are ligands for the nuclear
hormone liver X receptors and retinoic X receptors, respectively.
Functionally, the increased ABCA1 expression caused by these ligands
was followed by elevated apoA-I- and apoE-specific cholesterol efflux
in neurons and glia. In non-neuronal and neuronal cells overexpressing
a human Swedish variant of amyloid precursor protein,
22R-hydroxycholesterol and 9-cis-retinoic acid
induced ABCA1 expression and increased apoA-I-mediated cholesterol
efflux consequently decreasing cellular cholesterol content. More
importantly, we demonstrated that these ligands alone or in combination
with apoA-I caused a substantial reduction in the stability of amyloid precursor protein C-terminal fragments and decreased amyloid
22R-Hydroxycholesterol and 9-cis-Retinoic
Acid Induce ATP-binding Cassette Transporter A1 Expression and
Cholesterol Efflux in Brain Cells and Decrease Amyloid
Secretion*
§,
,
,
,
§
Pharmacology and
¶ Neurology, University of Pittsburgh School of Medicine,
Pittsburgh, Pennsylvania 15261
production. These effects of 22R-hydroxycholesterol may
provide a novel strategy to decrease amyloid
secretion and
consequently reduce the amyloid burden in the brain.
*
This work was supported by a pilot grant from the
Alzheimer's Disease Research Center Pittsburgh (to
R. P. K.), a pilot grant from the Pittsburgh Institute for
Neurodegenerative Disorders (to I. M. L.), National
Institutes of Health Grant AG 18558 (to J. S. L.), and by
the Fiske Drug Discovery Fund.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
This article has been cited by other articles:
![]() |
R. Kumar, D. McClain, R. Young, and G. A. Carlson Cholesterol transporter ATP-binding cassette A1 (ABCA1) is elevated in prion disease and affects PrPC and PrPSc concentrations in cultured cells J. Gen. Virol., June 1, 2008; 89(6): 1525 - 1532. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. L. Burgess, P. F. Parkinson, M. M. Racke, V. Hirsch-Reinshagen, J. Fan, C. Wong, S. Stukas, L. Theroux, J. Y. Chan, J. Donkin, et al. ABCG1 influences the brain cholesterol biosynthetic pathway but does not affect amyloid precursor protein or apolipoprotein E metabolism in vivo J. Lipid Res., June 1, 2008; 49(6): 1254 - 1267. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Guizzetti, J. Chen, J. F. Oram, R. Tsuji, K. Dao, T. Moller, and L. G. Costa Ethanol Induces Cholesterol Efflux and Up-regulates ATP-binding Cassette Cholesterol Transporters in Fetal Astrocytes J. Biol. Chem., June 29, 2007; 282(26): 18740 - 18749. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Zelcer, N. Khanlou, R. Clare, Q. Jiang, E. G. Reed-Geaghan, G. E. Landreth, H. V. Vinters, and P. Tontonoz Attenuation of neuroinflammation and Alzheimer's disease pathology by liver x receptors PNAS, June 19, 2007; 104(25): 10601 - 10606. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. H. Tansley, B. L. Burgess, M. T. Bryan, Y. Su, V. Hirsch-Reinshagen, J. Pearce, J. Y. Chan, A. Wilkinson, J. Evans, K. E. Naus, et al. The cholesterol transporter ABCG1 modulates the subcellular distribution and proteolytic processing of {beta}-amyloid precursor protein J. Lipid Res., May 1, 2007; 48(5): 1022 - 1034. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Guizzetti and L. Costa Cholesterol homeostasis in the developing brain: a possible new target for ethanol Human and Experimental Toxicology, April 1, 2007; 26(4): 355 - 360. [Abstract] [PDF] |
||||
![]() |
V. Hirsch-Reinshagen, J. Y. Chan, A. Wilkinson, T. Tanaka, J. Fan, G. Ou, L. F. Maia, R. R. Singaraja, M. R. Hayden, and C. L. Wellington Physiologically regulated transgenic ABCA1 does not reduce amyloid burden or amyloid-{beta} peptide levels in vivo J. Lipid Res., April 1, 2007; 48(4): 914 - 923. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Cavelier, L. Rohrer, and A. von Eckardstein ATP-Binding Cassette Transporter A1 Modulates Apolipoprotein A-I Transcytosis Through Aortic Endothelial Cells Circ. Res., November 10, 2006; 99(10): 1060 - 1066. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Koldamova, M. Staufenbiel, and I. Lefterov Lack of ABCA1 Considerably Decreases Brain ApoE Level and Increases Amyloid Deposition in APP23 Mice J. Biol. Chem., December 30, 2005; 280(52): 43224 - 43235. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Wahrle, H. Jiang, M. Parsadanian, R. E. Hartman, K. R. Bales, S. M. Paul, and D. M. Holtzman Deletion of Abca1 Increases Abeta Deposition in the PDAPP Transgenic Mouse Model of Alzheimer Disease J. Biol. Chem., December 30, 2005; 280(52): 43236 - 43242. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Hirsch-Reinshagen, L. F. Maia, B. L. Burgess, J.-F. Blain, K. E. Naus, S. A. McIsaac, P. F. Parkinson, J. Y. Chan, G. H. Tansley, M. R. Hayden, et al. The Absence of ABCA1 Decreases Soluble ApoE Levels but Does Not Diminish Amyloid Deposition in Two Murine Models of Alzheimer Disease J. Biol. Chem., December 30, 2005; 280(52): 43243 - 43256. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. F. Oram and J. W. Heinecke ATP-Binding Cassette Transporter A1: A Cell Cholesterol Exporter That Protects Against Cardiovascular Disease Physiol Rev, October 1, 2005; 85(4): 1343 - 1372. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-Y. Han, D. D. Liu, J. J. Lee, J. Kurie, R. Lotan, W. K. Hong, and H.-Y. Lee 9-cis-Retinoic Acid Treatment Increases Serum Concentrations of {alpha}-Tocopherol in Former Smokers Clin. Cancer Res., March 15, 2005; 11(6): 2305 - 2311. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. P. Koldamova, I. M. Lefterov, M. Staufenbiel, D. Wolfe, S. Huang, J. C. Glorioso, M. Walter, M. G. Roth, and J. S. Lazo The Liver X Receptor Ligand T0901317 Decreases Amyloid {beta} Production in Vitro and in a Mouse Model of Alzheimer's Disease J. Biol. Chem., February 11, 2005; 280(6): 4079 - 4088. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Wahrle, H. Jiang, M. Parsadanian, J. Legleiter, X. Han, J. D. Fryer, T. Kowalewski, and D. M. Holtzman ABCA1 Is Required for Normal Central Nervous System ApoE Levels and for Lipidation of Astrocyte-secreted apoE J. Biol. Chem., September 24, 2004; 279(39): 40987 - 40993. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Hirsch-Reinshagen, S. Zhou, B. L. Burgess, L. Bernier, S. A. McIsaac, J. Y. Chan, G. H. Tansley, J. S. Cohn, M. R. Hayden, and C. L. Wellington Deficiency of ABCA1 Impairs Apolipoprotein E Metabolism in Brain J. Biol. Chem., September 24, 2004; 279(39): 41197 - 41207. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Brown III, C. Theisler, S. Silberman, D. Magnuson, N. Gottardi-Littell, J. M. Lee, D. Yager, J. Crowley, K. Sambamurti, M. M. Rahman, et al. Differential Expression of Cholesterol Hydroxylases in Alzheimer's Disease J. Biol. Chem., August 13, 2004; 279(33): 34674 - 34681. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Wolozin Apolipoprotein E Receptor LR11: Intersections Between Neurodegeneration and Cholesterol Metabolism Arch Neurol, August 1, 2004; 61(8): 1178 - 1180. [Full Text] [PDF] |
||||
![]() |
L.-W. Jin, I. Maezawa, I. Vincent, and T. Bird Intracellular Accumulation of Amyloidogenic Fragments of Amyloid-{beta} Precursor Protein in Neurons with Niemann-Pick Type C Defects Is Associated with Endosomal Abnormalities Am. J. Pathol., March 1, 2004; 164(3): 975 - 985. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Y. Choi, B. Karten, T. Chan, J. E. Vance, W. L. Greer, R. A. Heidenreich, W. S. Garver, and G. A. Francis Impaired ABCA1-dependent Lipid Efflux and Hypoalphalipoproteinemia in Human Niemann-Pick type C Disease J. Biol. Chem., August 29, 2003; 278(35): 32569 - 32577. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Raffai and K. H. Weisgraber Cholesterol: from heart attacks to Alzheimer's disease J. Lipid Res., August 1, 2003; 44(8): 1423 - 1430. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Sun, J. Yao, T.-W. Kim, and A. R. Tall Expression of Liver X Receptor Target Genes Decreases Cellular Amyloid {beta} Peptide Secretion J. Biol. Chem., July 18, 2003; 278(30): 27688 - 27694. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Dietschy and S. D. Turley Thematic review series: Brain Lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal J. Lipid Res., August 1, 2004; 45(8): 1375 - 1397. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |